Merck’s Winrevair (sotatercept) gains UK approval for PAH treatment. Key trial results highlight significant exercise capacity improvements.
UK Approves Merck’s Hypertension Drug Acquired Via $11 Billion Acceleron Pharma Deal
Where Today's News Shapes Tomorrow
